Aurinia Pharmaceuticals Inc - Common Shares (AUPH) stock analysis

AUPH · Aurinia Pharmaceuticals Inc - Common Shares

Latest recorded price: USD 15.48

Sector and industry: Healthcare · Biotechnology

A reliable intrinsic value could not be calculated for AUPH; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 28.3%, ROIC 15.5%. The model flags 1 risk signal for this company.

Similar companies in Healthcare